Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell
• AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
This Oil Giant Is ‘Not Great, Not Bad,’ But Jim Cramer Says ‘I’m Sticking With My Coterra’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said BP (NYSE: BP) is "not great, not bad." He added, "This whole group is going through a real re-evaluation.
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell
• Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms.
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.
Why Are Aurinia Pharmaceuticals Shares Trading Higher Today
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) initiated an exploration of strategic alternatives, including a potential sale, merger, or
Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
Gainers
Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test.
Tesla, Nike, Sigilon Therapeutics Among Top Trending Stocks Today
U.S. stocks traded mixed at the closing bell today, with the Dow Jones Industrial Average gaining more than…
Aurinia Pharmaceuticals To Consider Range Of Options For Company Including, But Not Limited To, A Potential Sale, Merger Or Other Options
In Addition, Board has Accepted Recent Director Resignations and has Initiated a Search for New Directors
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ("Aurinia" or the "Company") today announced that
Aurinia Board Of Directors Announces Exploration Of Strategic Alternatives To Maximize Shareholder Value; Has Accepted Recent Director Resignations And Has Initiated A Search For New Directors
In Addition, Board has Accepted Recent Director Resignations and has Initiated a Search for New Directors
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ("Aurinia" or the "Company") today announced that